Daiichi-Sankyo (South Korea)
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent. Daiichi Sankyo, Inc. began operating in the U.S. in 2006. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Daiichi-Sankyo (South Korea), South Korea, covering academic research published from 2002 to 2024. Read More.
Open Access Percentage
74%
Total
Publications
282
Total Open
Publications
208
Total
Citations
7.6K
Open Access
Percentage
74%
Total
Publications
282
Total Open
Publications
208
Total
Citations
7.6K
Breakdown
Publisher Open
49%
Both
18%
Other Platform Open
5%
Closed
28%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 15%
26
Hybrid 19%
34
No Guarantees 66%
116
Other Platform Open
Domain 77%
47
Institution 28%
17
Other Internet 16%
10
Preprint 0%
0
Public 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 47 |
Unknown Repository | Other Internet | 5 |
DOI | Other Internet | 5 |
DANS - Data Archiving and Networked Services | Institution | 4 |
Europe PMC | Domain | 3 |
University of Southern Denmark - University of Southern Denmark Research Portal | Institution | 2 |
Elsevier - Scopus | Institution | 2 |
Yonsei University Medical Library - YUHSpace | Institution | 1 |
Università Politecnica delle Marche - Università Politecnica delle Marche | Institution | 1 |
University of Turin - Institutional Research Information System University of Turin | Institution | 1 |